久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Sirnaomics Oncology IND Receives Approval from FDA americanpharmaceuticalreview
    August 17, 2018
    Sirnaomics announces the U.S. Food and Drug Administration (FDA) has approved the company's first oncology IND application. The IND approval will allow for the study of the company's lead product candidate, STP705, in patients with advanced cholangiocarci

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service